RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...

Zimmerman and colleagues examined how many depressed patients who scored in the remission range on the 17-item Hamilton Depression Rating Scale (HDRS) did not consider themselves to be in remission ...

EEG-based machine learning predicted SSRI treatment response in depression with high accuracy. Learn how brain signals could ...

Investigational seltorexant improved symptoms of major depressive disorder (MDD) and insomnia in people with an inadequate response to antidepressants, a phase III trial indicated. By week 6, the ...

Objective This systematic review aims to evaluate the effectiveness of exercise interventions in alleviating depression and ...

An accelerated schedule of intermittent theta burst transcranial magnetic stimulation (aiTBS) completed in less than a week is effective for treatment-resistant bipolar depression, the results of a ...

GH Research announced positive Phase 2a trial results for GH001 in postpartum and bipolar II depression, with high remission rates. GH Research PLC announced significant progress in its clinical ...